Literature DB >> 33406242

A pan-cancer atlas of somatic mutations in miRNA biogenesis genes.

Paulina Galka-Marciniak1, Martyna Olga Urbanek-Trzeciak1, Paulina Maria Nawrocka1, Piotr Kozlowski1.   

Abstract

It is a well-known and intensively studied phenomenon that the levels of many miRNAs are differentiated in cancer. miRNA biogenesis and functional expression are complex processes orchestrated by many proteins cumulatively called miRNA biogenesis proteins. To characterize cancer somatic mutations in the miRNA biogenesis genes and investigate their potential impact on the levels of miRNAs, we analyzed whole-exome sequencing datasets of over 10 000 cancer/normal sample pairs deposited within the TCGA repository. We identified and characterized over 3600 somatic mutations in 29 miRNA biogenesis genes and showed that some of the genes are overmutated in specific cancers and/or have recurrent hotspot mutations (e.g. SMAD4 in PAAD, COAD and READ; DICER1 in UCEC; PRKRA in OV and LIN28B in SKCM). We identified a list of miRNAs whose level is affected by particular types of mutations in either SMAD4, SMAD2 or DICER1 and showed that hotspot mutations in the RNase domains in DICER1 not only decrease the level of 5p-miRNAs but also increase the level of 3p-miRNAs, including many well-known cancer-related miRNAs. We also showed an association of the mutations with patient survival. Eventually, we created an atlas/compendium of miRNA biogenesis alterations providing a useful resource for different aspects of biomedical research.
© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33406242      PMCID: PMC7826265          DOI: 10.1093/nar/gkaa1223

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  174 in total

1.  Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling.

Authors:  S Souchelnytskyi; K Tamaki; U Engström; C Wernstedt; P ten Dijke; C H Heldin
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

2.  A role for the P-body component GW182 in microRNA function.

Authors:  Jidong Liu; Fabiola V Rivas; James Wohlschlegel; John R Yates; Roy Parker; Gregory J Hannon
Journal:  Nat Cell Biol       Date:  2005-11-13       Impact factor: 28.824

3.  Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.

Authors:  Hushan Yang; Colin P Dinney; Yuanqing Ye; Yong Zhu; H Barton Grossman; Xifeng Wu
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 4.  Epigenetic activation of tumor suppressor microRNAs in human cancer cells.

Authors:  Yoshimasa Saito; Peter A Jones
Journal:  Cell Cycle       Date:  2006-10-01       Impact factor: 4.534

5.  Human polymorphism at microRNAs and microRNA target sites.

Authors:  Matthew A Saunders; Han Liang; Wen-Hsiung Li
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

6.  Impact of polymorphisms in microRNA biogenesis genes on colon cancer risk and microRNA expression levels: a population-based, case-control study.

Authors:  Lila E Mullany; Jennifer S Herrick; Roger K Wolff; Matthew F Buas; Martha L Slattery
Journal:  BMC Med Genomics       Date:  2016-04-23       Impact factor: 3.063

7.  DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions.

Authors:  Anello Marcello Poma; Vincenzo Condello; Maria Denaro; Liborio Torregrossa; Rossella Elisei; Paolo Vitti; Fulvio Basolo
Journal:  Oncotarget       Date:  2019-03-05

Review 8.  microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance.

Authors:  Ning Wang; Hor-Yue Tan; Yi-Gang Feng; Cheng Zhang; Feiyu Chen; Yibin Feng
Journal:  Cancers (Basel)       Date:  2018-12-20       Impact factor: 6.639

9.  TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN.

Authors:  Mitsuo Kato; Sumanth Putta; Mei Wang; Hang Yuan; Linda Lanting; Indu Nair; Amanda Gunn; Yoshimi Nakagawa; Hitoshi Shimano; Ivan Todorov; John J Rossi; Rama Natarajan
Journal:  Nat Cell Biol       Date:  2009-06-21       Impact factor: 28.824

10.  Mutational heterogeneity in cancer and the search for new cancer-associated genes.

Authors:  Michael S Lawrence; Petar Stojanov; Paz Polak; Gregory V Kryukov; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Chip Stewart; Craig H Mermel; Steven A Roberts; Adam Kiezun; Peter S Hammerman; Aaron McKenna; Yotam Drier; Lihua Zou; Alex H Ramos; Trevor J Pugh; Nicolas Stransky; Elena Helman; Jaegil Kim; Carrie Sougnez; Lauren Ambrogio; Elizabeth Nickerson; Erica Shefler; Maria L Cortés; Daniel Auclair; Gordon Saksena; Douglas Voet; Michael Noble; Daniel DiCara; Pei Lin; Lee Lichtenstein; David I Heiman; Timothy Fennell; Marcin Imielinski; Bryan Hernandez; Eran Hodis; Sylvan Baca; Austin M Dulak; Jens Lohr; Dan-Avi Landau; Catherine J Wu; Jorge Melendez-Zajgla; Alfredo Hidalgo-Miranda; Amnon Koren; Steven A McCarroll; Jaume Mora; Brian Crompton; Robert Onofrio; Melissa Parkin; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Charles W M Roberts; Jaclyn A Biegel; Kimberly Stegmaier; Adam J Bass; Levi A Garraway; Matthew Meyerson; Todd R Golub; Dmitry A Gordenin; Shamil Sunyaev; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2013-06-16       Impact factor: 49.962

View more
  5 in total

1.  tsRFun: a comprehensive platform for decoding human tsRNA expression, functions and prognostic value by high-throughput small RNA-Seq and CLIP-Seq data.

Authors:  Jun-Hao Wang; Wen-Xin Chen; Shi-Qiang Mei; Yue-Dong Yang; Jian-Hua Yang; Liang-Hu Qu; Ling-Ling Zheng
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

2.  The diagnostic and prognostic implications of PRKRA expression in HBV-related hepatocellular carcinoma.

Authors:  Yi-Min Hu; Ruoxi Ran; Chaoqi Yang; Song-Mei Liu
Journal:  Infect Agent Cancer       Date:  2022-06-21       Impact factor: 3.698

3.  Profile of Basal Cell Carcinoma Mutations and Copy Number Alterations - Focus on Gene-Associated Noncoding Variants.

Authors:  Paulina Maria Nawrocka; Paulina Galka-Marciniak; Martyna Olga Urbanek-Trzeciak; Ilamathi M-Thirusenthilarasan; Natalia Szostak; Anna Philips; Laura Susok; Michael Sand; Piotr Kozlowski
Journal:  Front Oncol       Date:  2021-11-25       Impact factor: 6.244

4.  Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin.

Authors:  Yuzhu Di; Yanan Jiang; Xiuyun Shen; Jing Liu; Yang Gao; Huimin Cai; Xiaoli Sun; Dandan Ning; Bing Liu; Jiaji Lei; Shizhu Jin
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

Review 5.  Emerging Role of isomiRs in Cancer: State of the Art and Recent Advances.

Authors:  Veronica Zelli; Chiara Compagnoni; Roberta Capelli; Alessandra Corrente; Jessica Cornice; Davide Vecchiotti; Monica Di Padova; Francesca Zazzeroni; Edoardo Alesse; Alessandra Tessitore
Journal:  Genes (Basel)       Date:  2021-09-20       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.